Panadol $50 mil. ad account goes to Ogilvy & Mather following SmithKline agency review.
This article was originally published in The Tan Sheet
Executive Summary
PANADOL $50 MIL. AD ACCOUNT ASSIGNED TO OGILVY & MATHER from BBDO, SmithKline Beecham announced June 27. BBDO dropped the big analgesic account earlier this month by "mutual agreement," resolving a standing conflict of interest, SmithKline said. O&M is one of SmithKline's two major global OTC product advertising agencies and has handled the company's Tagamet 100 brand in the U.K.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning